Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.
The drug, Aduhelm, has been mired in controversy since it [...]
The drug, Aduhelm, has been mired in controversy since it [...]
The drug, Aduhelm, brought in $300,000 in revenue in its [...]
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” [...]
For an increasingly important set of drugs, Medicare has been [...]
The drug from Biogen, called Aduhelm, is expected to generate [...]
Though some of its own senior officials said there was [...]
The rejection of the new Alzheimer’s drug by the two [...]
The agency’s acting head said a review should look into [...]